New perspectives on rheumatoid arthritis

Abstract

Rheumatoid arthritis (RA) remains one of the most common, puzzling and poorly treated diseases of humans. However, a surge of interest in the biology of chronic inflammation and in the design of more-potent and specific inhibitors of pro-inflammatory pathways heralds an optimistic era for the treatment of RA. A recent symposium* * The 4th Walter and Eliza Hall Institute Symposium on Rheumatoid Arthritis was held in Melbourne, Australia, on 18-20 May 1994. provided a multidisciplinary perspective on the current status of such studies. © 1994.